Researchers at Genentech/Roche presented the outcomes of three studies investigating pirfenidone’s action in IPF patients, during the American…
Articles by Patricia Inácio, PhD
Researchers at Weill Cornell Medicine showed that starving a group of immune cells by inhibiting the activity of the enzyme Arginase-1…
Analysis of pooled data from three international, randomized, and placebo-controlled clinical trails — the Phase 2 TOMORROW trial and two…
Hyaluronan synthase 2 (HAS2) deletion from fibrotic fibroblasts induces senescence (gradual deterioration) in the cells and fibrotic clearance in mouse models…
The heart’s right ventricle in systemic sclerosis patients is impaired when compared to people without the disease, according to a study…
In a recent study titled “UK asbestos imports and mortality due to idiopathic pulmonary fibrosis,” researchers highlighted…
A recent study showed that worsening symptoms of lung fibrosis in systemic sclerosis patients is linked to high levels of…
IVA337, the leading drug candidate from the biopharmaceutical company Inventiva, received a prize at the recent 4th Systemic Sclerosis…
Mitophagy, a protective mechanism against mitochondria reactive oxygen species (ROS), in lung macrophages is a key mechanism underlying the development…
An interaction between cells in the lungs’ vasculature appears to spur tissue regeneration and is a potential target for therapies against fibrosis, according…